These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 10413970

  • 1. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia.
    Fabron A, Moreira G, Bordin JO.
    Sao Paulo Med J; 1999 Jan 07; 117(1):38-9. PubMed ID: 10413970
    [Abstract] [Full Text] [Related]

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun 07; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 3. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease.
    Reyes MA, Illoh OC.
    Immunohematology; 2008 Jun 07; 24(2):45-51. PubMed ID: 19852130
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.
    Transfusion; 2002 Jan 07; 42(1):37-43. PubMed ID: 11896310
    [Abstract] [Full Text] [Related]

  • 5. Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice.
    Breiki ASA, Kindi SA, Castilho L.
    Immunohematology; 2024 Sep 01; 40(3):93-99. PubMed ID: 39373300
    [Abstract] [Full Text] [Related]

  • 6. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
    Jajosky RP, Lumm WC, Wise SC, Bollag RJ, Shikle JF.
    Immunohematology; 2017 Jun 01; 33(2):73-75. PubMed ID: 28657766
    [Abstract] [Full Text] [Related]

  • 7. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Fasano RM.
    Transfusion; 2017 Nov 01; 57(11):2738-2746. PubMed ID: 28840600
    [Abstract] [Full Text] [Related]

  • 8. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
    Coleman S, Westhoff CM, Friedman DF, Chou ST.
    Transfusion; 2019 Jul 01; 59(7):2282-2291. PubMed ID: 31021439
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Delayed hemolytic reaction to transfusion in sickle cell anemia. Report of one case].
    Moya F, Rivera M, Araya F, Donoso J, Sandoval P, Varas P.
    Rev Med Chil; 2018 Nov 01; 146(11):1347-1350. PubMed ID: 30725050
    [Abstract] [Full Text] [Related]

  • 11. Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood.
    Raciti PM, Francis RO, Spitalnik PF, Schwartz J, Jhang JS.
    J Clin Apher; 2013 Aug 01; 28(4):325-9. PubMed ID: 23450789
    [Abstract] [Full Text] [Related]

  • 12. Delayed hemolytic transfusion reactions in sickle cell anemia.
    Rao KR, Patel AR.
    South Med J; 1989 Aug 01; 82(8):1034-6. PubMed ID: 2762885
    [Abstract] [Full Text] [Related]

  • 13. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
    Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW.
    Transfusion; 2019 Jun 01; 59(6):1907-1910. PubMed ID: 30768787
    [Abstract] [Full Text] [Related]

  • 14. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.
    Jasinski S, Glasser CL.
    J Pediatr Hematol Oncol; 2019 Nov 01; 41(8):624-626. PubMed ID: 30179992
    [Abstract] [Full Text] [Related]

  • 15. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R, Hendrickson JE.
    Transfus Clin Biol; 2019 May 01; 26(2):112-115. PubMed ID: 30857806
    [Abstract] [Full Text] [Related]

  • 16. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA.
    Pediatr Blood Cancer; 2013 Sep 01; 60(9):1487-91. PubMed ID: 23508932
    [Abstract] [Full Text] [Related]

  • 17. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
    Kalyanaraman M, Heidemann SM, Sarnaik AP, Meert KL, Sarnaik SA.
    J Pediatr Hematol Oncol; 1999 Sep 01; 21(1):70-3. PubMed ID: 10029818
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
    Nickel RS, Hendrickson JE, Fasano RM, Meyer EK, Winkler AM, Yee MM, Lane PA, Jones YA, Pashankar FD, New T, Josephson CD, Stowell SR.
    Transfusion; 2016 Jan 01; 56(1):107-14. PubMed ID: 26509333
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.